TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
CEBPA |
SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive) |
Treatment: ethanol; Genotype: inducible version of CEBPA (C/EBPalpha-ER); |
Permissive
Robust
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
CEBPA |
SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive) |
Treatment: ethanol; Genotype: SKH1; |
Permissive
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
CEBPA |
SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive) |
Treatment: estradiol; Genotype: SKH1; |
Permissive
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
CEBPA |
Kasumi-1 (acute myeloblastic leukemia) |
Treatment: estradiol; Genotype: inducible version of CEBPA (C/EBPalpha-ER); |
Permissive
Robust
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
CEBPA |
Kasumi-1 (acute myeloblastic leukemia) |
Treatment: ethanol; Genotype: inducible version of CEBPA (C/EBPalpha-ER); |
Permissive
Robust
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
CEBPA |
Kasumi-1 (acute myeloblastic leukemia) |
Treatment: ethanol; Genotype: Kkasumi1; |
Permissive
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
CEBPA |
Kasumi-1 (acute myeloblastic leukemia) |
Treatment: estradiol; Genotype: Kkasumi1; |
Permissive
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
CEBPA |
MA9 transformed mouse leukemia |
Treatment: none Genotype: MLL-AF9 fusion |
Permissive
Robust
|
Mus musculus |
GSE100758
...
|
MA0019.1
...
|
CEBPA |
MA9 transformed mouse leukemia |
Treatment: LSD1 inhibitor GSK-LSD1 Genotype: MLL-AF9 fusion |
Permissive
Robust
|
Mus musculus |
GSE100758
...
|
MA0019.1
...
|
CEBPA |
line-bone marrow untransformed myeloid progenitors |
Strain: C57BL/6 Treatment: Stem cell (10ng/mL IL3, 10ng/mL IL6 100mg/mL SCF) for 7 days |
Permissive
Robust
|
Mus musculus |
GSE103446
...
|
MA0019.1
...
|
Showing 10 records in page 79
from 963 pages